Ranbaxy Laboratories Limited
Ranbaxy Laboratories Limited, the largest pharmaceutical company of India, is one among the top 10 generic drug making firm in the world. Incorporated in 1961, it markets in 125 countries with ground operations in 49 and manufacturing facilities in eleven countries. It produces a wide range of drugs in which its Anti-infectives amoxycillin, ciprofloxacin, and simvastatin are the most sellable drugs. Moreover, it also addresses gastrointestinal, cardiovascular, diabetes, pain, allergies, and HIV/AIDS as well as central nervous system disorders diseases. Its groundbreaking anti-malarial drug is still under trial and soon to be come in the market for countering falciparum malaria. In research field, it basically focuses on metabolic, inflammatory, and respiratory illnesses.

Japanese firm Daiichi Sankyo Company Ltd., in June 2008 has acquired this company. After that its global rank reached to among top 15 companies of the world. However, Malvinder Mohan Singh is still the Chairman, Managing Director and Chief Executive Officer of Ranbaxy.

View Ranbaxy Labs News

Ranbaxy Labs Latest News

97pc of emails are spam: Report - 09 Apr 2009
firm Message Labs, said he was amazed the Microsoft figure for unwanted e-mail

Armstrong refutes misbehaving charge - 08 Apr 2009
of labs or governments (the AFLD reports to the French government) doing drug

Markets go quiet, Sensex down 2.8 percent - 08 Apr 2009
were Tata Motors, up 4.95 percent at Rs.219.50; Ranbaxy, up 1.54 percent

Markets slip, but still in green - 06 Apr 2009
at Rs.1,570; Ranbaxy, down 1.15 percent at Rs.184.45, and ACC, down one percent

Sensex rises 193 points, ends in the green - 01 Apr 2009
.    Among the gainers on the 30-scrip composite Sensex were Ranbaxy

Markets quiet, still in the red - 01 Apr 2009
;  Among gainers on the 30-composite Sensex around this time were Ranbaxy

Boeing to develop aerospace technologies in Bangalore - 31 Mar 2009
labs across the US, and one overseas lab each in Australia and Spain - which

Bulls push Sensex up 140 points - 31 Mar 2009
Motors, up 4.64 percent at Rs.180.30; and Ranbaxy, up 4.58 percent at Rs.165.60.

Devon IT announces thin clients orderable from IBM in India - 31 Mar 2009
Sunil Bangalore, Program Director, India Software Labs IBM India Pvt. Ltd.  

Ranbaxy posts Rs.1,045 crore net loss in 2008 - 30 Mar 2009
Mumbai, March 30 (IANS) Leading drug maker Ranbaxy Laboratories Monday reported a net loss of Rs.1,044.8 crore ($204 million) for 2008 as against a net profit of Rs.617.7 crore in the previous year. However, the company's total income

View Ranbaxy Labs News